Blog tagged as FDA

Imaging plays a vital role in oncology trials, guiding how we track tumors and assess treatment success. But when trial sites vary in how they capture and interpret images, it can cloud the results. Learn why standardizing imaging is essential for clear, reliable insights in cancer research.

Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment led by Spring Mountain Capital, affirming Yunu’s position as an emerging category leader and proven innovator within the clinical trial imaging market.

This blog explores the critical need for consistency, collaboration, and tailored imaging approaches in multi-center trials. Learn how technology and standardization can improve imaging accuracy, streamline workflows, and enhance outcomes for patients.

A recent panel podcast on The Imaging Accuracy Crisis in Clinical Trials brought to light critical issues and innovative solutions that are reshaping the landscape of clinical trials.